54.31 USD
+0.08 (+0.15%)
54.31 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 74% to AKRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 64.26. This target is 18.32% above the current price.
AKRO was analyzed by 16 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about AKRO.
In the last month the buy percentage fell by 10 points. So the trust of analysts is decreasing.
AKRO was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-10 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-10-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-10-09 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-10-09 | Jefferies | Downgrade | Buy -> Hold |
| 2025-08-04 | TD Cowen | Initiate | Buy |
| 2025-05-27 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Citigroup | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-31 | UBS | Maintains | Buy -> Buy |
| 2025-01-30 | B of A Securities | Upgrade | Neutral -> Buy |
| 2025-01-28 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-28 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Citigroup | Initiate | Buy |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-12 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-05-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | B of A Securities | Reiterate | Neutral |
| 2024-03-05 | UBS | Maintains | Buy -> Buy |
| 2024-03-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
AKERO THERAPEUTICS INC / AKRO FAQ
What do analysts expect the price target to be for AKERO THERAPEUTICS INC (AKRO)?
16 analysts have analysed AKRO and the average price target is 64.26 USD. This implies a price increase of 18.32% is expected in the next year compared to the current price of 54.31.
What is the consensus rating for AKRO stock?
The consensus rating for AKERO THERAPEUTICS INC (AKRO) is 73.75 / 100 . This indicates that analysts generally have a positive outlook on the stock.